19 Mar

Analysts Are Divided on Johnson & Johnson Stock

WRITTEN BY Margaret Patrick

Analysts’ recommendations and target price

Wall Street analysts have given Johnson & Johnson (JNJ) a 12-month consensus target price of $144.71, 5.50% higher than the company’s closing price on March 18. The consensus analyst recommendation for the stock is a “buy.” Although analysts first revised the company’s target price downward from $145.50 in January to $144.22 in February, they raised it to $144.71 in March.

To learn about the key growth drivers and risks for Johnson & Johnson this year, read Here Are Some Possible Headwinds and Tailwinds for JNJ in 2019.

Analysts Are Divided on Johnson & Johnson Stock

Of the 18 analysts covering Johnson & Johnson, four analysts have given it “strong buys,” five have given it “buys,” eight have given it “holds,” and only one has given it a “sell.” The highest target price estimate for the company is $160, and the lowest is $123.

On March 18, Johnson & Johnson closed at $137.17, 0.31% lower than its previous closing price, 15.64% higher than its 52-week low of $118.62, and 7.93% lower than its 52-week high of $148.99. The company’s market cap is $366.42 billion.

Based on its closing price on March 18, Johnson & Johnson has reported returns of -1.00% in the last week, 2.13% in the last month, and -7.22% in the last quarter. The company has reported returns of -1.94% in the last half year, 3.09% in the last year, and 6.29% year-to-date.

Revenue and EPS estimates

Analysts expect Johnson & Johnson’s revenue to see YoY (year-over-year) changes of -1.94% to $19.62 billion in the first quarter, -1.93% to $20.43 billion in the second quarter, -0.96% to $20.15 billion in the third quarter, and 2.33% to $20.87 billion in the fourth quarter of 2019. Analysts also expect the company’s non-GAAP (generally accepted accounting principles) EPS to see YoY rises of 2.73% to $2.12 in the first quarter, 9.65% to $2.30 in the second quarter, 4.51% to $2.14 in the third quarter, and 2.28% to $2.01 in the fourth quarter.

Analysts expect Johnson & Johnson’s revenues to see YoY changes of -0.50% to $81.17 billion in 2019, 4.18% to $84.56 billion in 2020, and 4.37% to $88.26 billion in 2021. Analysts also expect the company’s non-GAAP EPS to see YoY rises of 4.93% to $8.58 in 2019, 5.76% to $9.08 in 2020, and 7.55% to $9.76 in 2021.

Latest articles

This year, Pfizer (PFE) stock has fallen 0.34% and Bristol-Myers Squibb (BMY) stock has fallen 6.48%. Both companies are focused on strengthening their position in the high-growth oncology and immunology markets. Let's take a closer look at each.

Walt Disney’s (DIS) latest movie, Toy Story 4, has reportedly broken records in the opening weekend with $118 million in sales. However, the opening weekend collection was behind analysts’ expectations of at least $150 million in the first weekend.

24 Jun

Will Home Depot’s Upward Momentum to Continue?

WRITTEN BY Rajiv Nanjapla

As of June 21, Home Depot (HD) was trading at $209.39, which implies a rise of 9.7% since the announcement of its first-quarter earnings on May 21. Also, the company was trading at a premium of 32.4% from its 52-week low of $158.09 and a discount of 2.8% from its 52-week high of $215.43.

On June 21, Aurora Cannabis (ACB) made an announcement that indicated that it will move towards higher margin vape products. In addition, the company also believes concentrates and edibles will command higher margins. In anticipation of this development, the company announced the expansion of its facility to capitalize on growth related to these segments.

Shares of Mondelēz International (MDLZ) are scaling new heights thanks to its stellar gains so far this year. Mondelēz stock is up 38.0% on a YTD (year-to-date) basis, and it closed at $55.25—just a shade lower than its 52-week high of $55.71—on June 21.

24 Jun

How Long Will Facebook's Libra Fuel Bitcoin Rally?

WRITTEN BY Mayur Sontakke, CFA, FRM

Ever since the news about Facebook’s (FB) cryptocurrency project broke, Bitcoin has rallied on the hope that Facebook’s entry in the space will help make cryptocurrencies mainstream. Facebook’s cryptocurrency will be called Libra and will be governed by an association with 28 founding members across industries.